Riskpilot← Back to searchSign inGet full accessNORDIC ORTOPEDICA AB
ABActiveOrg 5565344065Hyvelgatan 37 Lokal 1Manufacture of medical and dental instruments and supplies · NACE 3250Est. 19965 employees
Revenue 2024
SEK 20,9M
0% vs 2023
EBITDA margin
9.1%
+37% vs 2023
Equity ratio
50.1%
Financial strength
Net profit 2024
SEK 2,2M
+71% vs 2023
| Revenue | SEK 20,9M | +0% |
| EBITDA | SEK 1,9M | +37% |
| Net profit | SEK 2,2M | +71% |
| Total assets | SEK 35,4M | +5% |
| Equity | SEK 17,8M | +14% |
| Employees | 5 | — |
Legal name
NORDIC ORTOPEDICA AB
Org number
5565344065
Legal form
Aktiebolag
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
18 september 1996
Share capital
SEK 100 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-10-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna Eklund, Jeremiah Michael Mwangi
Company purpose
Föremålet för bolagets verksamhet är försäljning och tillverkning av ortopedtekniska artiklar samt därmed förenlig verksamhet.
Address
Hyvelgatan 37 Lokal 1
Phone
+4618349291
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 15 602 | 16 005 | 18 909 | 20 965 | 20 872 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 3 831 | 2 904 | 1 750 | 1 379 | 1 896 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −74 |
| EBIT | 3 831 | 2 904 | 1 750 | 1 379 | 1 822 |
| Net financials | −854 | −39 | −41 | −39 | 16 |
| Profit before tax | 3 501 | 3 686 | 1 707 | 1 820 | 2 738 |
| Tax | −864 | −797 | −354 | −563 | −584 |
| Net profit | 2 637 | 2 889 | 1 353 | 1 257 | 2 154 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 15 192 | 17 007 | 27 348 | 33 807 | 35 400 |
| Equity | 10 099 | 12 988 | 14 341 | 15 598 | 17 752 |
| Long-term debt | 473 | 375 | 285 | 195 | 105 |
| Short-term debt | 2 420 | 2 264 | 11 342 | 17 113 | 17 543 |
| Total debt | 2 893 | 2 639 | 11 627 | 17 308 | 17 648 |
EBITDA margin
9.1%
This company
15.8%
Market median
-42% vs market
20202024
Equity ratio
50.1%
This company
38.2%
Market median
+31% vs market
20202024
Return on equity
12.1%
This company
18.4%
Market median
+34% vs market
20202024
Net profit margin
10.3%
This company
8.1%
Market median
+27% vs market
20202024
Asset turnover
0.59×
This company
1.12×
Market median
-47% vs market
20202024
Debt / equity
0.99×
This company
0.62×
Market median
+60% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-11-01 – 2024-10-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-11-01 – 2023-10-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-11-01 – 2022-10-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-11-01 – 2021-10-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-11-01 – 2020-10-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
JM External Signatory | External Signatory | 2022 |
GL Chief Auditor | Chief Auditor | 2022 |
| Former (2) | ||
CJ External Signatory | External Signatory | 2020 – 2022 |
SA External Signatory | External Signatory | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2020 | |
| Board of Directors | 2022 | |
| Chairman | 2020 | |
| Former (2) | ||
| Deputy Board Member | 2020 – 2022 | |
| Board of Directors | 2020 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ABILITY MATTERS GROUP LIMITED
NORDIC ORTOPEDICA AB (this company)Board members of NORDIC ORTOPEDICA AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jeremiah Michael Mwangi Eklund | External Signatory | 0 companies |
| Christopher Jakob Scheutz | External Signatory | 0 companies |
| Shanaz Ahmed | External Signatory | 0 companies |
| Gabriel Lars Dan Forssenius | Chief Auditor | 0 companies |
| Mark Ferdinand Verheul | Board of Directors | 0 companies |
| Roelof Marten Ter Wee | Deputy Board Member | 0 companies |
| Mark Constant Killaars | Board of Directors | 0 companies |
| Paul David Robinson | Board of Directors | 0 companies |
| John O Byrne | Chairman | 0 companies |